158 related articles for article (PubMed ID: 10822225)
21. [Severe postmenopausal hyperandrogenism due to an ovarian lipoid cell tumor: a case report].
Bernasconi D; Del Monte P; Marinaro E; Marugo A; Marugo M
Minerva Endocrinol; 2004 Mar; 29(1):25-9. PubMed ID: 15258555
[TBL] [Abstract][Full Text] [Related]
22. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
[TBL] [Abstract][Full Text] [Related]
23. Hilus cell tumour of the ovary in a virilized, premenopausal woman. Case report and review of hyperandrogenism of ovarian origin.
Moore A; Permezel M; Mulvany N; Pepperell RJ
Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):75-8. PubMed ID: 10099755
[TBL] [Abstract][Full Text] [Related]
24. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
[TBL] [Abstract][Full Text] [Related]
25. Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman.
Marcondes JA; Curi DD; Matsuzaki CN; Barcellos CR; Rocha MP; Hayashida SA; Baracat EC
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1184-8. PubMed ID: 19082308
[TBL] [Abstract][Full Text] [Related]
26. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
[TBL] [Abstract][Full Text] [Related]
27. Ovarian steroid cell tumor as an example of severe hyperandrogenism in 45-year-old woman.
Szeliga A; Zysnarska A; Podfigurna A; Maciejewska-Jeske M; Moszyński R; Sajdak S; Jasiński P; Frankowski A; Genazzani AR; Męczekalski B
Gynecol Endocrinol; 2020 Apr; 36(4):303-307. PubMed ID: 31718336
[TBL] [Abstract][Full Text] [Related]
28. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
Escobar-Morreale H; Pazos F; Potau N; García-Robles R; Sancho JM; Varela C
Fertil Steril; 1994 Sep; 62(3):521-30. PubMed ID: 8062947
[TBL] [Abstract][Full Text] [Related]
29. Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
Shearer JL; Salmons N; Murphy DJ; Gama R
Ann Clin Biochem; 2017 Jan; 54(1):174-177. PubMed ID: 27278937
[TBL] [Abstract][Full Text] [Related]
30. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
31. [In vivo and in vitro effects of GnRH analogs on ovarian Leydig cell tumor].
Emons G; Ortmann O; Pahwa GS; Löhrs U; Wetterling T; Dilling H; Oberheuser F; Knuppen R
Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):487-93. PubMed ID: 1327941
[TBL] [Abstract][Full Text] [Related]
32. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
33. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
[TBL] [Abstract][Full Text] [Related]
34. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman.
Souto SB; Baptista PV; Barreto F; Sousa PF; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2012 Dec; 56(9):672-6. PubMed ID: 23329192
[TBL] [Abstract][Full Text] [Related]
35. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
[TBL] [Abstract][Full Text] [Related]
36. Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report.
Adefris M; Fekadu E
J Med Case Rep; 2017 Aug; 11(1):242. PubMed ID: 28851436
[TBL] [Abstract][Full Text] [Related]
37. An unusual steroid-producing ovarian tumour: case report.
Stephens JW; Katz JR; McDermott N; MacLean AB; Bouloux PM
Hum Reprod; 2002 Jun; 17(6):1468-71. PubMed ID: 12042263
[TBL] [Abstract][Full Text] [Related]
38. Abnormalities in the serum insulin-like growth factor-1 axis in women with hyperandrogenism.
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Varela C; Sancho JM
Fertil Steril; 1998 Dec; 70(6):1090-100. PubMed ID: 9848301
[TBL] [Abstract][Full Text] [Related]
39. Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF.
Yim SF; Lok IH; Cheung LP; Briton-Jones CM; Chiu TT; Haines CJ
Hum Reprod; 2001 Mar; 16(3):492-4. PubMed ID: 11228217
[TBL] [Abstract][Full Text] [Related]
40. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF
Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
